Melanin-concentrating hormone analogs
CA 2399509 A1 · Owner: Merck & Co. Inc. · Inventors: Bednarek, Maria
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention features truncated MCH analogs active at the MCH receptor. The truncated MCH analogs are optionally modified peptide derivatives of mammalian MCH. The analogs can bind to the MCH receptor and preferably, bring about signal transduction. MCH analogs have a variety of different uses including being used as a research tool and being used therapeutically.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 1, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 1, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 1, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.